192 related articles for article (PubMed ID: 8944665)
1. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1.
Nakabayashi H; Nishizawa M; Nakagawa A; Takeda R; Niijima A
Am J Physiol; 1996 Nov; 271(5 Pt 1):E808-13. PubMed ID: 8944665
[TBL] [Abstract][Full Text] [Related]
2. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor.
Nishizawa M; Nakabayashi H; Kawai K; Ito T; Kawakami S; Nakagawa A; Niijima A; Uchida K
J Auton Nerv Syst; 2000 Apr; 80(1-2):14-21. PubMed ID: 10742535
[TBL] [Abstract][Full Text] [Related]
3. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein.
Nishizawa M; Nakabayashi H; Uchida K; Nakagawa A; Niijima A
J Auton Nerv Syst; 1996 Nov; 61(2):149-54. PubMed ID: 8946334
[TBL] [Abstract][Full Text] [Related]
4. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.
Nishizawa M; Nakabayashi H; Uehara K; Nakagawa A; Uchida K; Koya D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E376-87. PubMed ID: 23715725
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
[TBL] [Abstract][Full Text] [Related]
7. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.
Wettergren A; Wøjdemann M; Holst JJ
Am J Physiol; 1998 Nov; 275(5):G984-92. PubMed ID: 9815028
[TBL] [Abstract][Full Text] [Related]
9. Arginine sensors in the hepato-portal system and their reflex effects on pancreatic efferents in the rat.
Tanaka K; Inoue S; Takamura Y; Jiang ZY; Niijima A
Neurosci Lett; 1986 Dec; 72(1):69-73. PubMed ID: 3808463
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic vagal nerve is receptive to somatostatin in rats.
Nakabayashi H; Niijima A; Kurata Y; Jiang ZY; Usukura N; Takeda R
Am J Physiol; 1987 Jul; 253(1 Pt 2):R200-3. PubMed ID: 2886061
[TBL] [Abstract][Full Text] [Related]
11. Glycine sensor in the hepato-portal system and their reflex effects on pancreatic efferents in the rat.
Saitou S; Tanaka K; Inoue S; Takamura Y; Niijima A
Neurosci Lett; 1993 Jan; 149(1):12-4. PubMed ID: 8469371
[TBL] [Abstract][Full Text] [Related]
12. Reflex effects of oral, gastrointestinal and hepatoportal glutamate sensors on vagal nerve activity.
Niijima A
J Nutr; 2000 Apr; 130(4S Suppl):971S-3S. PubMed ID: 10736363
[TBL] [Abstract][Full Text] [Related]
13. Intraportal mercaptoacetate infusion increases afferent activity in the common hepatic vagus branch of the rat.
Lutz TA; Diener M; Scharrer E
Am J Physiol; 1997 Jul; 273(1 Pt 2):R442-5. PubMed ID: 9249583
[TBL] [Abstract][Full Text] [Related]
14. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat.
Niijima A
J Auton Nerv Syst; 1996 Dec; 61(3):287-91. PubMed ID: 8988487
[TBL] [Abstract][Full Text] [Related]
15. A unique receptor-mediated mechanism in vagal chemoreception of somatostatin in the hepatoportal area.
Nakabayashi H; Niijima A; Nishizawa M; Nakabayashi IO; Takeda R
J Auton Nerv Syst; 1994 Dec; 50(1):45-50. PubMed ID: 7844313
[TBL] [Abstract][Full Text] [Related]
16. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats.
Barragán JM; Eng J; Rodríguez R; Blázquez E
Am J Physiol; 1999 Nov; 277(5):E784-91. PubMed ID: 10567003
[TBL] [Abstract][Full Text] [Related]
17. Hepatic glucose-sensitive unit regulation of glucose-induced insulin secretion in rats.
Nagase H; Inoue S; Tanaka K; Takamura Y; Niijima A
Physiol Behav; 1993 Jan; 53(1):139-43. PubMed ID: 8381973
[TBL] [Abstract][Full Text] [Related]
18. Glycation of glucagon-like peptide-1(7-36)amide: characterization and impaired action on rat insulin secreting cells.
O'Harte FP; Abdel-Wahab YH; Conlon JM; Flatt PR
Diabetologia; 1998 Oct; 41(10):1187-93. PubMed ID: 9794106
[TBL] [Abstract][Full Text] [Related]
19. Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats.
Fujiwara K; Gotoh K; Chiba S; Masaki T; Katsuragi I; Kakuma T; Yoshimatsu H
J Neurochem; 2012 Apr; 121(1):66-76. PubMed ID: 22035323
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
